Ownership history in WEALTH EFFECTS LLC · 17 quarters on record
This page tracks every 13F SEC filing in which WEALTH EFFECTS LLC reported a position in ARROWHEAD PHARMACEUTICALS IN (ARWR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 143,300 | -25,150 | -14.9% | 2.98% | $9.5M | $66.39 |
| 2025 Q3 | ADDED | 168,450 | +2,800 | +1.7% | 1.87% | $5.8M | $34.49 |
| 2025 Q2 | REDUCED | 165,650 | -4,900 | -2.9% | 0.98% | $2.6M | $15.80 |
| 2025 Q1 | ADDED | 170,550 | +14,675 | +9.4% | 0.91% | $2.2M | $12.74 |
| 2024 Q4 | REDUCED | 155,875 | -4,150 | -2.6% | 1.04% | $2.9M | $18.80 |
| 2024 Q3 | ADDED | 160,025 | +425 | +0.3% | 1.09% | $3.1M | $19.37 |
| 2024 Q2 | REDUCED | 159,600 | -4,860 | -3.0% | 1.50% | $4.1M | $25.99 |
| 2024 Q1 | ADDED | 164,460 | +2,610 | +1.6% | 1.73% | $4.7M | $28.60 |
| 2023 Q4 | REDUCED | 161,850 | -2,900 | -1.8% | 1.86% | $5.0M | $30.60 |
| 2023 Q3 | ADDED | 164,750 | +700 | +0.4% | 2.19% | $4.4M | $26.87 |
As of 2025 Q4 — sorted by position size